SAMPRE NUTRITIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Intimation of Board meeting to consider and approve unaudited standalone and consolidated financial results of the company for the quarter ended 31 December 2024 and proposal for raising of funds.

pdf

Sampre Nutritions Ltd.

10 Jan 2025

39.51

1.99%

Company Update

SAMPRE NUTRITIONS LTD. - 530617 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

certificate under Reg 74(5) of SEBI (DP) Regulations

pdf

Sampre Nutritions Ltd.

03 Jan 2025

39.51

1.99%

Company Update

SAMPRE NUTRITIONS LTD. - 530617 - Revised Financial Results For The Quarter And Half-Year Ended 30 …

BSE India

Further to the communication received from the BSE, the company has uploaded the revised financial results for the Quarter and Half-Year ended 30 September 2024. The nature of change is only in the format of the Limited Review Report of the Consolidated Financial Statements which is in line with the applicable SEBI Circular(s). The financial figures and other information remain unchanged.

pdf

Sampre Nutritions Ltd.

28 Dec 2024

39.51

1.99%

SAST

SAMPRE NUTRITIONS LTD. - 530617 - Closure of Trading Window

BSE India

Trading window for dealing shares in the company shall remain closed for designated persons with effect from 01-01-2025 till 48 hours of declaration of the results approved by the Board.

pdf

Is Sampre Nutritions Ltd. worth buying?

25 Votes:

Buy 84.0%

Sell 8.0%

Hold 8.0%

60.95% Fall from 52W High

High volume today

Sampre Nutritions Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sampre Nutritions Ltd. on BSE